Table 2 Intraoperative and postoperative data of patients with or without achieving TOO after laparoscopic pancreaticoduodenectomy
Variables | TOO (n = 44, 25.73%) | Non-TOO (n = 127, 74.27%) | P value |
|---|---|---|---|
Tumor size (cm)b | 3.00 (2.50–4.15) | 3.00 (2.50–4.00) | 0.337 |
OT (min)a | 381.80 ± 82.96 | 387.36 ± 93.98 | 0.729 |
EBL (mL)b | 150 (100–200) | 200 (100–300) | 0.989 |
Blood transfusion (n (%)) | 7 (15.91%) | 17 (13.39%) | 0.678 |
Diameter of MPD (mm)b | 4 (3–6) | 4 (3–5) | 0.652 |
DGE (n (%)) | 3 (6.82%) | 31 (24.41%) | 0.011 |
CR-POPF (n (%)) | 0 (0%) | 4 (3.15%) | 0.234 |
PPH (n (%)) | 1 (2.27%) | 4 (3.15%) | 0.755 |
Infection of incisional wound (n (%)) | 0 (0%) | 4 (3.15%) | 0.203 |
Intra-abdominal infection (n (%)) | 0 (0%) | 9 (7.09%) | 0.067 |
PV/SMV resection (n (%)) | 12 (27.27%) | 48 (37.80%) | 0.208 |
Nerve invasion (n (%)) | 30 (68.18%) | 94 (74.02%) | 0.365 |
Vascular invasion (n (%)) | 14 (31.82%) | 42 (33.07%) | 0.564 |
Pathologic T stage (n (%)) | |||
pT1 | 3 (6.82%) | 21 (16.54%) | 0.339 |
pT2 | 29 (65.91%) | 81 (63.78%) | |
pT3 | 12 (27.27%) | 25 (19.69%) | |
Pathologic N stage (n (%)) | |||
pN0 | 31 (70.45%) | 84 (66.14%) | 0.415 |
pN1 | 10 (22.73%) | 38 (29.92%) | |
pN2 | 3 (6.82%) | 5 (3.94%) | |